Nplate 500 MCG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FHNQ3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,252
Award facts
- Contract value 100% obligated
- $10,252.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $10,252.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nplate 500 micrograms vials. The delivery order, issued on November 24, 2025, with an ultimate completion date of December 16, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to establish regional prime vendor contractors for military pharmaceutical supply needs.
The PPV-G GEN V contract, awarded to DMS Pharmaceutical Group on November 13, 2025, with a ceiling value of $499,999,999 and completion date of December 31, 2036, authorizes the Defense Logistics Agency to issue delivery orders for comprehensive pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare operations globally. As a critical pharmaceutical supplier within the federal military medical supply chain since 2001, DMS Pharmaceutical Group has demonstrated substantial capability across diverse product categories and has established consistent contract performance in fulfilling specialized pharmaceutical requirements for military healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DR26FHNQ3?
SPE2DR26FHNQ3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FHNQ3 worth?
The government has obligated $10,252 on SPE2DR26FHNQ3.
Is contract SPE2DR26FHNQ3 an order under another contract?
Yes. SPE2DR26FHNQ3 is a delivery order under SPE2DR25D9231, an indefinite delivery contract.
Was contract SPE2DR26FHNQ3 competed?
The extent of competition for SPE2DR26FHNQ3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award